JPRN-UMIN000008795招募中未知
Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate to teeth extraction sockets for dental implant in Japanese participants - Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Person who is diagnosed as osteoporosis 2 Person who is suffered from bone disease 3 Person who is not allowed the treatment with lithium carbonate 4 Person who is treated with the medicine which may cause drug interaction with lithium carbonate 5 Body weight<40 kg, >90 kg 6 Person who has a periapical lesion in object tooth 7 Person who has 1- or 2-wall infrabony defects after object tooth extraction 8 Person judged as inappropriate by research contact person
研究者
相似试验
未知
1 期
Phase11 study of OPB-51602 in patients with hematologic malignanciesmultiple myeloma [MM], non-Hodgkin lymphoma [NHL], acute myeloid leukemia [AML], acute lymphoid leukemia [ALL], chronic myeloid leukemia [CML]JPRN-jRCT2080221439Otsuka Pharmaceutical Co., Ltd.
进行中（未招募）
1 期
Dose-Escalation Study to Evaluate the Safety and Tolerability of SCH 717454 in Combination with Different Treatment Regimens in Subjects with Advanced Solid Tumors (Phase 1b/2; Protocol No. P04722) - N/AColorectal Adenocarcinoma, Non-small Cell Lung Cancer, Gastric Adenocarcinoma, Her2+ Breast Cancer, Renal Cell Cancer, Pancreatic AdenocarcinomaMedDRA version: 12.0 Level: LLT Classification code 10001150 Term: Adenocarcinoma gastricMedDRA version: 12.0 Level: LLT Classification code 10065430 Term: HER-2 positive breast cancerMedDRA version: 12.0 Level: LLT Classification code 10038407 Term: Renal cell cancerMedDRA version: 12.0 Level: LLT Classification code 10051971 Term: Pancreatic adenocarcinomaMedDRA version: 12.0 Level: PT Classification code 10052360 Term: <Manually entered code. Term in E.1.1>MedDRA version: 12.0 Level: PT Classification code 10061873 Term: <Manually entered code. Term in E.1.1>EUCTR2009-011101-16-GBSchering-Plough Research Institute, A Division of Schering Corporation250
已完成
不适用
Dose-escalation study to evaluate safety and tolerability of cellobiose in healthy subjectsHealthy volunteersDRKS00012972Pfeifer & Langen GmbH & Co. KG48
已完成
不适用
Dose-escalation study to evaluate safety and gastrointestinal tolerability of allulose in subjects compared to placeboHealthy subjectsDRKS00017848Pfeifer & Langen GmbH & Co. KG49
已完成
1 期
A programme to develop a skin patch containing two medicines (physostigmine and hyoscine) - study 2: Assessment of blood levels of the two medicines and any associated symptoms in healthy male participants wearing four prototype skin patchesPotential risk of poisoning by nerve agentInjury, Occupational Diseases, PoisoningPoisoningISRCTN29062676Defence Science and Technology Laboratory (Dstl)24